Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Patent
1994-09-02
1995-12-05
Ivy, C. Warren
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
546269, 564281, 549282, C07D31178, C07D40710
Patent
active
054730830
ABSTRACT:
The invention features phototherapeutic compositions comprising Type 1, Type 2, or Type 3 psoralens and methods of using such compounds for treatment of proliferative diseases of skin, blood and bone marrow.
REFERENCES:
patent: 4124598 (1978-11-01), Hearst et al.
patent: 4130568 (1978-12-01), Confalone et al.
patent: 4151291 (1979-04-01), Vallet
patent: 4294822 (1981-10-01), Kaufman
patent: 4312883 (1982-01-01), Baccichetti et al.
patent: 4452811 (1984-06-01), della Valle
patent: 4737517 (1988-04-01), della Valle et al.
patent: 4950770 (1990-08-01), Heindel et al.
Isaacs et al., "Biochemistry", vol. 16, No. 6, pp. 1058-1064, 1979.
"Coumarins From Brosimum Gaudichaudii"; by Wagner Viegas et al.; Journal of Natural Products, vol. 56, Mar. 1993; pp. 416-417.
"Extracorporeal Photopheresis in the Treatment of AIDS-Related Complex: A Pilot Study" by Emil Bisaccia et al.; American College of Physicians 1990; pp. 270-275.
"Syntheses of Psoralen Analogues and Evaluation of Their Inhibition of Epidermal Growth Factor Binding"; by Ned Heindel et al.; Journal of Pharmaceutical Sciences vol. 80, No. 7, Jul. 1991; pp. 686-689.
"Treatment of Autoimmune Disease with Extracorporeal Photochemotherapy: Progressive Systemic Sclerosis"; by Alain Rook et al.; The Yale Journal of Biology and Medicine 62 (1989) pp. 639-645.
"Treatment of Autoimmune Disease with Extracorporeal Phtochemotherapy: Pemphigus Vulgaris-Preliminary Report"; by Alain Rook et al.; The Yale Journal of Biology & Medicine 62 (1989) pp. 647-652.
"Photophresis Therapy of Cutaneous T-Cell Lymphoma: The Yale-New Haven Hospital Experience"; by Peter Heald et al.; The Yale Journal of Biology & Medicine 62 (1989), pp. 629-638.
"Experimental Murine and Primate Models for Dissection of the Immunosuppressive Potential of Photochemotherapy in Autoimmune Disease & Transplantation"; by C. Berger; The Yale Journal of Biology & Medicine 62 (1989), pp. 611-620.
"Photochemistry of the Psoralens"; by John Hearst; Chem. Res. in Toxicology, vol. 2, Mar./Apr. 1989 pp. 69-75.
"Light-Activated Drugs"; by R. Edelson, Scientific American; Aug. 1988; pp. 68-75.
"Photo-CIDNP as a tool for the Study of the Reactivity of Photosensitizing Drugs: The Furocoumarins"; by J. Marko et al.; Photochemistry & Photobiology vol. 47, pp. 1-13, 1988.
"Characterization of a Photoalkylated Psoralen Receptor in HeLa Cells"; by E. Yurkow et al.; The Journal of Biological Chem.; vol. 262; 1987; pp. 8349-8442.
"Synthesis of Methyl Derivatives of 8-Desmethylxanthyletine and 8-Desmethylsesline, Potential Antiproliferative Agents"; by P. Rodighiero et al.; J. Heterocyclic Chem., 24, 1987, pp. 485-488.
"Psoralens potentiate ultraviolet light-induced inhibition of epidermal growth factor binding"; by J. Laskin et al.; Proc. Natl. Acad. Sci. USA, vol. 83, 1986, pp. 8211-8215.
"Nitrations of 4',5'-Dihydropsoralens: A Route to Radiopharmaceutical Precursors"; by N. Heindel et al.; J. Heterocyclic Chem. 23, 1579 (1986); pp. 1579-1582.
"A possible mechanism of psoralen phototoxicity not involving direct interaction with DNA"; by J. Laskin et al.; Proc. Natl. Acad. Sci. USA, V 82, 1985, pp. 6158-6162.
"Aminomethyl Psoralens. Electrophilic Substitution of Hydroxymethylphthalimide on Linear Furocoumarins"; by N. Heindel et al.; J Heterocyclic Chem, 1985, pp. 73-76.
"Psoralen and Ultraviolet A Effects on Epidermal Ornithine Decarboxylase Induction and DNA Synthesis in the Hairless Mouse .sup.1,2 "; by N. Lowe et al.; Natl. Cancer Institute, Monographs 66:73-76, 1984.
"Cutaneous Squamous-cell Carcinoma in Patients Treated with PUVA"; by R. Stern et al.; The New England Journal of Medicine; 1984, pp. 1156-1161.
"Transfer Hydrogenation of Furocoumarin Derivatives"; by Ned Heindel et al.; Journal of Organic Chemistry, 1983, pp. 3817-3819.
"Epidermal ornithine decarboxylase activity and thymidine incorporation following treatment with ultraviolet A combined with topical 8-methoxypsoralen or anthracene in the hairless mouse"; by R. Gange; British Journal of Dermatology (1981) 105,, pp. 247-255.
"Ultraviolet Light and Epidermal Polyamines"; N. Lowe; Journal of Investigative Dermatology, 77:147-153, 1981.
"A Convenient Synthesis of Psoralen Derivatives: Psoralen, 4-Methyl-psoralen and 4-Phenyl-psoralen"; by V. Ahluwalia et al.; Monatshefte fur Chemie 111, pp. 877-882, 1980.
"Psoralen Photochemotherapy of Cutaneous Disorders"; by T. Anderson et al.; Ann. Rev. Pharmacol. Toxicol. 1980, 20:235-257.
"Ultraviolet Light Induces Epidermal Ornthine Decarboxylase Activity"; N. Lowe et al.; The Journal of Investigative Dermatology, 71:417-418, 1978.
"Synthesis & Characterization of New Psoralen Derivatives with Superior Photoreactivity with DNA and RNA "; S. Isaacs et al., Biochemistry, v. 16, 1977; pp. 1058-1064.
"Induction of the Polyamine-biosynthetic Enzymes in Mouse Epidermis by Tumor-promoting Agents"; by T. O'Brien et al.; Cancer Res. vol. 35, 1975, pp. 1662-1670.
"Repair of DNA Containing Interstrand Crosslinks in Escherichia coli: Sequential Excision & Recombination"; by R. Cole; Proc. Nat. Acad. Sci. USA; 1973, pp. 1064-1068.
CA90(15):121567g "Psoralens", Hearst et al. p. 644, 1979.
CA96(25):213337j "Photochemotheraply a new promising chemical derivative", Willis, p. 331, 1982.
CA102(25):217553s "Psoralens: a search for more effective derivatives for photochemotherapeutic regimens", Willis et al.; p. 299, 1985.
CA114(17):162520u "Sensitizers of the room-temperature phosphorescence of biacetyl in fats", Sargi, et al.; p. 623, 1991.
Heindel Ned D.
Laskin Jeffrey D.
Ivy C. Warren
Lehigh University
Trinh Ba K.
University of Medicine and Dentistry of New Jersey
LandOfFree
Reduced and quaternized psoralens as photo-activated therapeutic does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Reduced and quaternized psoralens as photo-activated therapeutic, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Reduced and quaternized psoralens as photo-activated therapeutic will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1375157